Desh Rakshak

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE971E01016
NSEID:
BSEID: 531521

INR

30.49

-1.6 (-4.99%)

BSENSE

Dec 19

BSE+NSE Vol: 300

{
  "main_header": {
    "sid": 351394,
    "name": "Desh Rakshak",
    "stock_name": "Desh Rakshak",
    "full_name": "Desh Rakshak Aushdhalaya Ltd",
    "name_url": "stocks-analysis/desh-rakshak",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.49",
    "chg": -1.6,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "32.09",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531521,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE971E01016",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "300 ",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Desh Rakshak Aushdhalaya Faces Mixed Signals Amidst Market and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/desh-rakshak-aushdhalaya-downgraded-to-strong-sell-amid-technical-weakness-and-flat-financials-3750456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DeshRakshakAush_mojoScore_3750456.png",
        "date": "2025-12-08 08:10:32",
        "description": "Desh Rakshak Aushdhalaya, a key player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market assessment. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters, painting a nuanced picture for investors navigating the current landscape."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-intense-selling-pressure-amid-lower-circuit-lockdown-3748718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DeshRakshakAush_only_sellers_3748718.png",
        "date": "2025-12-05 10:25:32",
        "description": "Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers. This development comes amid a series of consecutive losses over recent months, signalling distress selling and heightened market caution."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3746838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DeshRakshakAush_only_sellers_3746838.png",
        "date": "2025-12-04 13:41:33",
        "description": "Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-hits-upper-circuit-amidst-unprecedented-buying-interest-3735827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3735827.png",
        "date": "2025-11-28 15:15:49",
        "description": "Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3731118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3731118.png",
        "date": "2025-11-26 10:10:31",
        "description": "Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-unprecedented-buying-interest-amidst-price-decline-3730812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3730812.png",
        "date": "2025-11-26 09:50:35",
        "description": "Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3728104.png",
        "date": "2025-11-25 09:40:40",
        "description": "Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3725368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3725368.png",
        "date": "2025-11-24 11:30:32",
        "description": "Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Desh Rakshak overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-desh-rakshak-overvalued-or-undervalued-3723547",
        "imagepath": "",
        "date": "2025-11-24 08:09:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Desh Rakshak’s Current Valuation Metrics</strong></p>\n<p>As of 21 Nov 2025, Desh Rakshak’s valuation grade was revised to fair, reflecting a more balanced assessment compared to its previous expensive rating. The company’s price-to-earnings (PE) ratio stands at 37.17, which is relatively high but not uncommon in the pharmaceutical industry, where growth prospects often justify premium multiples. The price-to-book (P/B) ratio of 1.90 suggests the stock is trading at nearly twice its book value, indicating moderate investor confidence in its asset base and future earnings potential.</p>\n<p>Enterprise value multiples further support this fair valuation stance. The EV to EBIT ratio is 23.04, while EV to EBITDA is 14.92, both figures signalling a valuation that is elevated but not e..."
      }
    ],
    "total": 190,
    "sid": "351394",
    "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394"
  },
  "announcements": [
    {
      "caption": "Submission Of Newspaper Publication For 44Th Annual General Meeting Pursuant To Para A Of Part A Of Schedule III Read With Regulation 30And Regulation 47 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "08-Dec-2025",
      "details": "Please Find Enclosed herewith advertisement published in newspapers informing about the 44th Annual General Meeting pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "06-Dec-2025",
      "details": "Intimation regarding Consideration of regularisation of Mr. Rajesh Kumar Gupta (DIN: 01048355) Regularisation of Mrs. Cheena Golani (DIN: 11220936) and re-appointment of Mr. Tosh Kumar Jain (DIN: 01540363)",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Notice Of 44Th Annual General Meeting For The Financial Year 2024-2025",
      "datetime": "06-Dec-2025",
      "details": "Notice of 44th AGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Desh Rakshak Aushdhalaya Faces Mixed Signals Amidst Market and Financial Trends

2025-12-08 08:10:32

Desh Rakshak Aushdhalaya, a key player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its market assessment. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters, painting a nuanced picture for investors navigating the current landscape.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-05 10:25:32

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers. This development comes amid a series of consecutive losses over recent months, signalling distress selling and heightened market caution.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-04 13:41:33

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks.

Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

2025-11-28 15:15:49

Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-26 10:10:31

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context.

Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-11-26 09:50:35

Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 09:40:40

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 11:30:32

Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector.

Is Desh Rakshak overvalued or undervalued?

2025-11-24 08:09:52

Understanding Desh Rakshak’s Current Valuation Metrics

As of 21 Nov 2025, Desh Rakshak’s valuation grade was revised to fair, reflecting a more balanced assessment compared to its previous expensive rating. The company’s price-to-earnings (PE) ratio stands at 37.17, which is relatively high but not uncommon in the pharmaceutical industry, where growth prospects often justify premium multiples. The price-to-book (P/B) ratio of 1.90 suggests the stock is trading at nearly twice its book value, indicating moderate investor confidence in its asset base and future earnings potential.

Enterprise value multiples further support this fair valuation stance. The EV to EBIT ratio is 23.04, while EV to EBITDA is 14.92, both figures signalling a valuation that is elevated but not e...

View All News

Announcement

Submission Of Newspaper Publication For 44Th Annual General Meeting Pursuant To Para A Of Part A Of Schedule III Read With Regulation 30And Regulation 47 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

08-Dec-2025 | Source : BSE

Please Find Enclosed herewith advertisement published in newspapers informing about the 44th Annual General Meeting pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Change in Directorate

06-Dec-2025 | Source : BSE

Intimation regarding Consideration of regularisation of Mr. Rajesh Kumar Gupta (DIN: 01048355) Regularisation of Mrs. Cheena Golani (DIN: 11220936) and re-appointment of Mr. Tosh Kumar Jain (DIN: 01540363)